JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 25, 2007; DOI: 10.1124/jpet.107.125567


0022-3565/07/3231-391-397$20.00
JPET 323:391-397, 2007
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.107.125567v1
323/1/391    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, X.-H.
Right arrow Articles by Xu, H.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, X.-H.
Right arrow Articles by Xu, H.-B.

CARDIOVASCULAR

Activation of Large-Conductance Calcium-Activated Potassium Channels by Puerarin: The Underlying Mechanism of Puerarin-Mediated VasodilationFormula

Xiao-Hui Sun, Jiu-Ping Ding, Hui Li, Na Pan, Lu Gan, Xiang-Liang Yang, and Hui-Bi Xu

Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, People's Republic of China

Received May 9, 2007; accepted July 24, 2007.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Puerarin is the main isoflavone found in Pueraria lobata (Willd) Ohwi, which has been used in therapy for various cardiovascular diseases. The present study examined the effects of puerarin on the large-conductance voltage- and Ca2+-activated potassium (BKCa) channel and on rat thoracic aortas. BKCa channels encoded with either {alpha} (BK-{alpha}) or {alpha}/beta subunits (BK-{alpha}+beta1) were heterologously expressed in Xenopus oocytes or human embryonic kidney 293 cells. The activities of BKCa channels were measured using excised patch-clamp recordings. Puerarin activated BK-{alpha}+beta1 currents with a half-maximal concentration (EC50) of 0.8 nM and a Hill coefficient of 1.11 at 10 µMCa2+ and with an EC50 of 12.6 nM and a Hill coefficient of 1.08 at 0 µMCa2+. Puerarin (1 nM) induced a 16-mV leftward shift in the conductance-voltage curve for BK-{alpha}+beta1 currents at 10 µMCa2+ and at 100 nM induced a 26-mV leftward shift at 0 µMCa2+. Puerarin mainly increased the BK-{alpha}+beta1 channel open probability without changing the unitary conductance. Activation was also detected in the absence of the beta1 subunit. A deglycosylated analog of puerarin, daidzein, also activated BKCa channels with weaker potency. In addition, puerarin (0.1 to 1000 µM) caused concentration-dependent relaxations of rat thoracic aortic rings contracted with 1 µM noradrenaline bitartrate (EC50 = 1.1 µM). These were significantly inhibited by 50 nM iberiotoxin, a specific blocker of BKCa channels. This is the first study demonstrating that puerarin activates BKCa channels, especially BK-{alpha}+beta1 channels. The activation of the BKCa channel probably contributes to the puerarin-mediated vasodilation action.


Puerarin [7-hydroxy-3-(4-hydroxyphenyl)-1-benzopyran-4-one 8-(beta-D-glucopyranoside), Fig. 1] is the main isoflavone isolated from the Chinese medicinal herb Ge-gen (also known as "Kudzu" in the West), the root of the wild leguminous creeper Pueraria lobata (Willd) Ohwi. Puerarin has multiple pharmacological activities (Gao, 2003Go) and has been used to treat many cardiovascular diseases such as hypertension (Song et al., 1988Go; Wu et al., 2006Go), angina (Chen, 2004Go; Wang et al., 2006Go), and myocardial infarction (Xiao et al., 2005Go; Zhang et al., 2006Go). The vascular relaxing action of puerarin is one of the focuses of research on its pharmacology. It involves a variety of molecular mechanisms such as activation of endothelial nitric-oxide synthase (Ma et al., 2003Go) and the cAMP pathway (Yeung et al., 2006Go). Some researchers (Sun and Li, 2002Go; Dong et al., 2004Go) have shown that the potassium channel blocker tetraethylammonium can significantly block puerarin-induced vasodilation. Other studies have shown that puerarin blocks the L-type Ca2+ channel and the K+ channel in isolated guinea pig ventricular myocytes (Miao et al., 1998Go; Qian et al., 1999Go; Zhang et al., 2001Go) and inhibits the Na+ current in rat ventricular myocytes (Zhang et al., 2003Go). However, there are no reports of effects of puerarin on K+ channels in smooth muscle cells.


Figure 1
View larger version (38K):
[in this window]
[in a new window]

 
Fig. 1. Activation of mslo+hbeta1 channels coexpressed in Xenopus oocytes by puerarin. A, all traces were recorded in inside-out patches at 10 µM intracellular Ca2+. Top, representative traces under conditions of control, 1 nM puerarin, and washout as indicated. Currents were evoked by voltage steps in the range from–180 to +100 mV for 30 ms in 20-mV steps, after a prepulse to–180 mV as shown at bottom right. Middle, G-V curves from individual patches were normalized and then averaged. The fitted values for the V50 of control and in the presence of 1 nM puerarin are–27 ± 3 and–43 ± 4mV(p < 0.01, n = 6), respectively. Bottom, the voltage dependence of the activation of mslo+hbeta1 currents by 1 nM puerarin at 10 µMCa2+ calculated from the data in the middle panel. *, p < 0.05 versus control, n = 6. B, all traces were recorded in inside-out patches at 0 µM intracellular Ca2+. Top, representative traces are shown under conditions of control, 100 nM puerarin and washout as indicated. Middle, the fitted values for the V50 of control and 100 nM puerarin are 164 ± 6 and 138 ± 11 mV (p < 0.01, n = 5), respectively. The inset shows the chemical structure of puerarin. Bottom, the voltage dependence of the activation of mslo+hbeta1 currents by 100 nM puerarin at 0 µMCa2+ was re-evaluated from the data shown in middle panel. *, p < 0.05 versus control, n = 5.

 
The BKCa channel, the large-conductance voltage- and Ca2+-activated potassium channel abundantly expressed in vascular smooth muscle cells, plays a critical role in controlling vascular tone. Activation of BKCa channels leads to hyperpolarization of the cell membrane, which causes deactivation of voltage-dependent calcium channels and vasodilation (Brenner et al., 2000Go). Deletion of the BKCa channel leads to high blood pressure in small arteries of mice (Sausbier et al., 2005Go). The smooth muscle BKCa channels are typically composed of four pore-forming {alpha} subunits and an unknown number of regulatory beta1 subunits. The accessory beta1 subunits of BKCa channels play a vital role in coupling Ca2+ sparks to BKCa channel activation in vascular smooth muscles (Chang et al., 2006Go). Its down-regulation has been shown to play an important role in hypertension (Plüger et al., 2000Go; Amberg et al., 2003Go).

In this study, we investigated the effects of puerarin on cloned BKCa channels and examined the vasodilation effects of puerarin in the presence or absence of the specific BKCa channel blocker iberiotoxin (IbTX). These results may help to understand the underlying mechanisms of puerarin-mediated vasodilation.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Materials. Puerarin and daidzein (7,4'-dihydroxyisoflavone) were purchased from the Chinese National Institute for the Control of Pharmaceutical and Biological Products (purity ≥99%; Beijing, China). Daidzein was dissolved with dimethyl sulfoxide. The final concentration of dimethyl sulfoxide did not exceed 0.1%, which did not alter the kinetic properties of BKCa channels (data not shown). All of the other chemicals were obtained from Sigma-Aldrich (St. Louis, MO) except where indicated.

Expression of mslo and hbeta1 Channels in Xenopus Oocytes. Methods of expression of mslo and hbeta1 channels in stage V to VI Xenopus oocytes were described previously (Xia et al., 1999Go; Yao et al., 2005Go). In brief, oocytes were digested by treatment with 2 mg/ml collagenase I in zero calcium ND-96 solution. Between 2 and 24 h after digestion, 1 to 2 ng (mslo and hbeta1) of cRNA (a gift of Dr. Christopher Lingle, Washington University, St. Louis, MO) was injected into Xenopus oocytes using a Drummond Nanoject II (Drummond Scientific Co., Broomall, PA). After injection, oocytes were then incubated in ND-96 solution at 18°C. Currents were recorded 2 to 7 days after RNA injection. ND-96 solution (pH 7.5) contained the following concentrations: 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 2.5 mM sodium pyruvate, and 10 mM H+-HEPES. It was supplemented with 100 IU/ml penicillin and 100 µg/ml streptomycin for incubation.

Expression of dslo Channels in HEK293 Cells. Human embryonic kidney 293 (HEK293) cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA) with 10% fetal bovine serum (McCartney et al., 2005Go). HEK293 cells grew on 24-well plates at a density of ~1 x 104/well and were transfected with 0.6 µg of green fluorescent protein/pcDNA3.1 and 0.6 µg of dslo/pcDNA3.1 (a gift of Dr. Christopher Lingle) using Lipofectamine 2000 (Invitrogen). Cells were used for electrophysiological recordings in 1 to 2 days after transfection.

Electrophysiology. Patch pipettes were pulled from borosilicate glass capillaries with a resistance between 2 and 5 megaohms. All experiments in excised patch configurations were performed and recorded using a PC2C patch-clamp amplifier (Inbio Life Science Instrument Co., Ltd., Wuhan City, China) and PClamp software (Molecular Devices, Sunnyvale, CA). Currents were typically digitized at 20 kHz. Macroscopic records were filtered at 10 kHz during digitization. Single-channel records were filtered at 5 kHz and digitized at 10 kHz. For an inside-out patch experiment, the intracellular solution contained 160 mM MeSO3K, 10 mM H+-HEPES, and 2 mM MgCl2, adjusted to pH 7.0 with methanesulfonic acid (MeSO3H). The bath solution contained 160 mM MeSO3K, 10 mM H+-HEPES, and 5mM N-hydroxyethylenediaminetriacetic acid with Ca2+ added to make 10 µM free Ca2+, as defined by the EGTAETC program (E. McCleskey, Vollum Institute, Portland, OR), with the pH adjusted to 7.0.

During recording, drugs and control/wash solutions were puffed locally onto the cell via a puffer pipette containing seven solution channels. The tip (~300 µm diameter) of the puffer pipette was located approximately 120 µm from the cell. As determined by conductance tests, the solution around a cell under study was fully controlled by the application solution with a flow rate of 100 µl/min or greater. All experiments were done at room temperature (22–25°C).

Vasoreactivity Measurements. Male Wistar rats (weighing 200 ~ 250 g; obtained from the Animal Center, Institute of Health and Epidemic Prevention, Hubei, China) were sacrificed by decapitation under ether anesthesia. The thoracic aortas were excised and cleaned of adherent connective tissue and were cut into 3-mm ring segments. The endothelial layer was removed in some experiments by gently rubbing the intimal surface of the vessels with a hypodermic needle. Conversely, in other cases, the endothelium was maintained. Arterial rings were mounted on two stainless steel hooks in 5-ml organ baths filled with Krebs-Ringer buffer (pH 7.4) of the following composition: 119 mM NaCl, 25 mM NaHCO3, 11.1 mM glucose, 1.6 mM CaCl2, 4.7 mM KCl, 1.2 mM KH2PO4, and 1.2 mM MgSO4 and gassed with a mixture of 95% O2/5% CO2. The rings were equilibrated for 45 min at +37°C with a resting tension of 1.0 g. During this period, the bathing solution was replaced every 15 min, and if necessary, the basal tone was readjusted to 1.0 g. After the equilibration, the endothelial removal/integrity was confirmed by the administration of acetylcholine (10 µM) to noradrenaline bitartrate (NA; 1 µM)-precontracted vascular rings. A relaxation <10% of the NA-induced contraction was considered the representative of an acceptable lack of the endothelial layer, whereas a relaxation ≥70% of the NA-induced contraction was considered the representative of an acceptable integrity of the endothelium. Rings were then washed in prewarmed Krebs-Ringer solution until the baseline tone was regained. The rings were then contracted with 1 µM NA to the maximal contraction. Following washout of NA, cumulative concentration-response curves to stepwise cumulative addition of puerarin (0.1~1000 µM) with or without 50 nM IbTX were established. Each new addition of puerarin was made after the response to the previous addition had attained a steady state. The force of contraction was measured with an isometric force-displacement transducer and registered with a polygraph (RM6240 transducer, RM6240B/C Polygraph; Chengdu Instrument Co., Chengdu, China). Relaxation responses were expressed as a percentage of NA-induced contraction. All animal experiments were approved by the Institutional Animal Care and Use Committee and were in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (publication 85-23, revised 1996).

Data Analysis. Data were analyzed with Clampfit (Molecular Devices), SigmaPlot (SPSS Inc., Chicago, IL), and QUB (State University of New York, Buffalo, NY) software. Unless indicated, the data are presented as means ± S.E.M.; statistical significance between two groups and among multiple groups was tested using Student's t test and one-way analysis of variance, respectively. Differences in the mean values were considered significant at a probability of <0.05. Dose-response relationships for puerarin activating BKCa channels and relaxing rat thoracic aortic rings were fitted to a Hill equation of the following form: f = fmax/(1 + (EC50 /[puerarin])n), where f is activation percentage of BKCa currents or relaxation percentage of rat thoracic aortic rings, fmax is maximum value of f, and [puerarin] is the concentration of puerarin. EC50 and n denote the puerarin concentration of half-maximal effect and the Hill coefficient, respectively. G-V curves were fitted to a Boltzmann equation of following form: G/Gmax = 1/(1 + exp[(VV50)/k]), where G is the conductance of the channel, Gmax is the maximal G, V is the holding potential, V50 is the voltage for half-maximal activation, and k represents the slope factor. G-V curves were generated from steady-state currents. Single-channel analysis was performed using QUB. Single-channel amplitudes were measured by using an all-points histogram of current records. NPO (the open probability for a multichannel patch) was determined over at least 10 s of recording. NPO values were calculated from the area under the curve of the Gaussian fit of all-points amplitude histograms. Assuming a Poisson distribution, NPO = {Sigma}i*Xi, with i = 1... n, where n is the maximum number of simultaneous conducting channels during the observation period, and Xi is the relative area under the curve corresponding to each opening.


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Puerarin Activating Macroscopic BK-{alpha}+beta1 Channel Currents. Macroscopic BKCa currents in Xenopus oocytes coexpressing mslo and hbeta1 (mslo+hbeta1) were obtained at different potentials in excised patches. Puerarin does not activate BKCa channel currents when applied to the outside of excised cell membrane patches, even at 100 µM concentration (data not shown). However, puerarin potently activated channels when applied to the cytoplasmic side of excised cell membrane in the presence of 0 and 10 µM intracellular Ca2+ (Fig. 1). Figure 1A shows the voltage dependence of puerarin-induced enhancement of BKCa currents at 10 µMCa2+. Application of 1 nM puerarin significantly increased the currents at negative potentials, and the activation was partially reversible. The middle panel summarizes the relationships between conductance and voltage. Puerarin (1 nM) resulted in a 16-mV leftward shift of the V50 of G-V curves. The bottom panel shows the enhancement percentage of BKCa currents by puerarin at different potentials. The activation of BKCa channel currents by puerarin was markedly inverse voltage-dependent; i.e., there was a larger increase at lower potentials (76.6 ± 13.5 and 27.5 ± 6.1% at–40 and–20 mV, respectively, p < 0.05, versus control, n = 6). Figure 1B summarizes the activation by 100 nM puerarin at 0 µMCa2+. Puerarin (100 nM) also stimulated BKCa currents and induced a 26-mV leftward shift in the V50 of G-V curves.

Currents of mslo+hbeta1in Xenopus oocytes shown in Fig. 2 were recorded in inside-out patches at–20 and +100 mV with 10 and 0 µM Ca2+, respectively. In Fig. 2A, 1 nM puerarin increased BKCa currents, and the time courses of the currents, which were activated at various concentrations of puerarin, indicate that the whole process goes in a rapid and partially reversible manner. The dose-response curve is fitted to a Hill equation with an EC50 of 0.8 nM and a Hill coefficient of 1.11. Likewise, puerarin increased the BKCa currents at +100 mV and zero Ca2+ concentration (Fig. 2B). However, the EC50 and the Hill coefficient derived from the dose-response curve in this case are 12.6 nM and 1.08, respectively, indicating that Ca2+ facilitates activation by puerarin.


Figure 2
View larger version (33K):
[in this window]
[in a new window]

 
Fig. 2. Concentration dependence of puerarin activation of mslo+hbeta1 currents. A, traces show the activation of BKCa currents coexpressed with mslo and hbeta1 subunits in Xenopus oocytes by 1 nM puerarin in the presence of 10 µM internal Ca2+. Top, example traces show the BKCa currents from an inside-out patch before, during, and after application of 1 nM puerarin at–20 mV. The dashed line represents zero current. Middle, plots show the time course of activation of BKCa currents, which were normalized to control, from four different inside-out patches in the presence of 0.1, 0.5, 1, and 5 nM puerarin at–20 mV. Currents were recorded every 5 s. Bottom, the solid line is a fit to the Hill equation. The EC50 of the dose-response curve of puerarin activation of BKCa currents was 0.8 nM with a Hill coefficient 1.11 (*, p < 0.05 versus control, n = 4). B, the time course and the dose-response curves of puerarin activation of BKCa currents are shown in the middle and bottom panels, at +100 mV and zero intracellular Ca2+. The time course was obtained from an inside-out patch during application of 5, 10, 20, and 100 nM puerarin. Currents were recorded every 15 s. The EC50 value was 12.6 nM with a Hill coefficient 1.08 (*, p < 0.05 versus control, n = 4).

 
The Effect of Puerarin on Single BK-{alpha}+beta1 Channel Currents. Single-channel currents of mslo+hbeta1 were recorded in inside-out patches at 10 µM free Ca2+ concentration. Figure 3 and Supplemental Fig. 1 show the effect of puerarin on the single BK-{alpha}+beta1 channel currents at–20 and +50 mV, respectively. In Fig. 3A, the initial NPO was 0.51, and after the application of 1 nM puerarin the NPO was increased to 0.70. The single-channel amplitude was almost unchanged after the application of 1 nM puerarin. A summary of the effects of 1 nM puerarin on NPO and the unitary amplitude of single BKCa channels at–20 mV is shown in Fig. 3B. Puerarin induced a 37 ± 7% enhancement in NPO and slight changes in unitary amplitude at–20 mV (n = 6). To further confirm any possible change in single BKCa channel conductance caused by puerarin, a series of experiments was performed at several holding potentials ranging from–60 to +60 mV with 10 µMCa2+. In Fig. 3C, the current-voltage plots show that there is no significant change in conductance before and after the application of 1 nM puerarin (242.8 ± 12.4 and 248.5 ± 16.0 pS, control and plus puerarin, respectively, n = 6).


Figure 3
View larger version (33K):
[in this window]
[in a new window]

 
Fig. 3. Effects of puerarin on single-channel characteristics of BKCa channels coexpressed with mslo and hbeta1 subunits in Xenopus oocytes at 10 µMCa2+. A, single-channel traces were obtained from an inside-out patch before (Control) and after application of 1 nM puerarin. Channels were held at–20 mV in symmetrical 160 KCl solutions. The letters c, o1, and o2 indicate the close, open 1, and open 2 levels, respectively. Records a and b are insets of square section. Each histogram (bottom) illustrates all possible change in open probabilities and unitary conductance after applying puerarin. B, summary of the effect of 1 nM puerarin on NPO (left) and unitary amplitude (right) of single BKCa channels at–20 mV. **, p < 0.01 versus control, n = 6. C, single-channel current-voltage curves are plotted in the absence and presence of 1 nM puerarin (n = 6).

 
Puerarin Activating Currents of BK-{alpha} (mslo) Channel. One often asks whether the auxiliary beta1 subunit of BKCa channels plays a critical role in the activation of BKCa currents by puerarin A (Giangiacomo et al., 1998Go; Pérez, 2005Go; Zakharov et al., 2005Go). Consequently, we have further explored the effect of puerarin in the absence of the beta1 subunit. A series of experiments shown in Fig. 4 were conducted at zero Ca2+ concentration. Under those conditions, puerarin also shows an activation effect on mslo currents but at higher concentrations. Figure 4A shows that 1 µM puerarin significantly activates mslo currents with an 18-mV leftward shift in the V50. The dose-response curve was fitted to a Hill equation with an EC50 of 166.6 nM and a Hill coefficient of 0.72 (Fig. 4B).


Figure 4
View larger version (16K):
[in this window]
[in a new window]

 
Fig. 4. Activation by puerarin of BKCa channels in the absence of the beta1 subunit at zero Ca2+ concentration. A, top, representative traces of BKCa currents expressed with mslo subunits in Xenopus oocytes were obtained from an inside-out patch before (left) and after (right) application of 1 µM puerarin. The voltage protocol is shown in the inset. Bottom, the V50 of G-V curves for control and 1 µM puerarin are 169 ± 3 and 151 ± 1mV (p < 0.01, n = 5), respectively. B, the concentration-dependent activation curve of mslo obtained from five different patches at + 100 mV. The experimental points were fitted to a Hill function (solid line) with a Hill coefficient of 0.72. The EC50 obtained from the fit was 166.6 nM. *, p < 0.05 versus control, n = 4.

 

Puerarin Has No Effect on dslo Currents. To estimate the domain of BKCa channels that puerarin may bind to, the BKCa encoded with dslo subunit expressed in HEK293 cells was used. Puerarin has no effect on the dslo currents at 0 µM Ca2+ (data not shown) and 10 µMCa2+ (Fig. 5). Therefore, we infer that the possible interaction domain may locate at the S0-S1 and S8-S9 linkers, because the BKCa dslo channel contains the above regions significantly different from that of the BKCa mslo channel.


Figure 5
View larger version (24K):
[in this window]
[in a new window]

 
Fig. 5. Lack of effect of puerarin on BKCa currents expressed with dslo subunits in HEK293 cells. A, example current traces of dslo are shown before (left) and after (right) application of 1 µM puerarin at 10 µM internal Ca2+. Currents were activated at potentials from–180 through +200 mV for 150 ms in 20-mV increments after a prepulse to–180 mV, as shown in inset. B, the V50 of G-V curves are as follows: for control (open symbols), V50 control = 95 ± 6 mV; and for 100 nM puerarin (filled symbols), V50 puerarin = 100 ± 7mV(n = 5). Error bars represent S.E.M.

 
Daidzein, an Analog to Puerarin, Activating mslo Currents. Daidzein is an aglycone of puerarin, in other words, it is a hydrolysate of puerarin. To investigate the role of beta-D-glycosyl residue at 8-position of the puerarin isoflavone core in the activation process of BKCa channels, the effect of daidzein on BKCa mslo channels was examined at zero Ca2+ concentration. In Fig. 6, 1 µM daidzein also increases BKCa currents in inside-out patches with an 11-mV leftward shift in the V50, which is smaller than that of puerarin of 18-mV shift as shown in Fig. 4A. That means that the beta-D-glycosyl residue also plays a role in enhancing channels.


Figure 6
View larger version (27K):
[in this window]
[in a new window]

 
Fig. 6. Activation of mslo currents by daidzein, an analog to puerarin. A, example traces of mslo channels expressed in Xenopus oocytes were obtained from an inside-out patch before (left) and after (right) application of 1 µM daidzein at zero Ca2+. The voltage protocol is shown at the right bottom. B, the V50 of G-V curves are V50 control = 159 ± 9mV (Control, open symbols) and V50 daidzein = 148 ± 5mV(1 µM daidzein, filled symbols) (p < 0.01, n = 5). Error bars represent S.E.M. The chemical structure of daidzein is shown in inset.

 

Puerarin Relaxing Rat Thoracic Aortic Rings. Puerarin (0.1 to 1000 µM) caused concentration-dependent relaxations in endothelium-intact and endothelium-denuded rat thoracic aortic rings contracted with NA (1 µM) (Fig. 7). The EC50 was 1.1 and 2.2 µM, and the maximal relaxation was 45.9 ± 5.1% (n = 5) and 33.5 ± 4.6% (n = 6) to endothelium-intact and endothelium-denuded aortic rings, respectively, indicating that endothelium was involved in puerarin-induced vasodilation. The specific BKCa channel blocker IbTX (50 nM) significantly inhibited puerarin-induced relaxations on both endothelium-intact and endothelium-denuded aortic rings, the fractional inhibition at a puerarin concentration of 1 µM on endothelium-intact and endothelium-denuded aortic rings was 34.0 and 48.0%, respectively, suggesting that the activation of BKCa channels also contributes to the puerarin-mediated vasodilation action.


Figure 7
View larger version (26K):
[in this window]
[in a new window]

 
Fig. 7. Puerarin-induced relaxation of isolated rat thoracic aortas. Rings were contracted with NA (1 µM) before puerarin (0.1 to 1000 µM) was added cumulatively. Concentration-response curves were obtained on endothelium-intact (circles) or endothelium-denuded (diamonds) aortic rings, in the absence (filled symbols) or in the presence (open symbols) of 50 nM IbTX. *, p < 0.05 versus endothelium-intact group; #, p < 0.05 versus endothelium-denuded group. The inset shows the fractional inhibition of relaxation by 50 nM IbTX at puerarin concentration of 1, 10, and 100 µM on endothelium-intact (filled bars) or endothelium-denuded (open bars) vessels.

 


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
The major findings of this study are as follows. Puerarin potently activated BK-{alpha}+beta1 currents in the nanomolar concentration range. It increased the activity of BK-{alpha}+beta1 channels with no change in single-channel conductance. Puerarin also stimulated BK-{alpha} currents with weaker potency. A puerarin analog, daidzein, activated BK-{alpha} currents with weaker potency than puerarin. Puerarin dilated rat thoracic aortic rings in a concentration-dependent manner, and this relaxation response could be inhibited by IbTX.

Mechanisms of the Effect of Puerarin on BKCa Channels. Puerarin potently activated cloned BK-{alpha}+beta1 channels, shifting the G-V relationship to the left in cell-free patches. Compared with many other natural BKCa channel openers, including BMS-204352 (EC50 ≥ 300 nM) (Gribkoff et al., 2001Go), dehydrosoyasaponin-I (EC50 ≥ 100 nM) (Giangiacomo et al., 1998Go), and mallotoxin (effective concentration ≥500 nM) (Zakharov et al., 2005Go), the effective concentration range for puerarin is considerably lower (EC50 values, 0.8 nM at 10 µMCa2+ and 12.6 nM at 0 µMCa2+). The effect of puerarin on BKCa channels is in a voltage- and Ca2+-dependent manner. It is very notable that the effect of puerarin is inverse voltage-dependent; i.e., the activation of BKCa channels by puerarin is significantly larger at negative potentials, which is similar to another BKCa channel opener 12,14-dichlorodehydroabietic acid (Sakamoto et al., 2006Go). The EC50 of puerarin on BKCa channels is a 16-fold augmentation at zero Ca2+ compared with at 10 µMCa2+, which may imply that Ca2+ facilitates the activation of puerarin. On the other side, Ca2+ produced a more leftward shift in V50 of BKCa channels in the presence of puerarin than that in the absence of puerarin; e.g., the V50 of BK-{alpha}+beta1 was–27 ± 3 mV in the absence of 1 nM puerarin but–43 ± 4 mV in the presence of 1 nM puerarin at 10 µMCa2+, indicating that puerarin was able to increase the Ca2+ sensitivity of BKCa channel gating. Single-channel recordings showed that puerarin mainly increased the BKCa channel NPO without changing the unitary conductance. In addition, the Hill coefficients of dose-response curves were approximately unity both at 10 and 0 µMCa2+, suggesting only one site for interaction between puerarin and the BKCa channel protein.

The Role of the beta1 Subunit. Puerarin activating BKCa channels was also observed in the absence of the beta1 subunit, which indicates that beta1 subunit is not required for the activation. However, puerarin has a stronger effect on the BK-{alpha}+beta1 channels than the BK-{alpha} channel alone. In the absence of the beta1 subunit, the EC50 of puerarin is greater by 13 times, suggesting that the role of the beta1 subunit is probably to facilitate puerarin binding. The beta1 subunit is composed of two transmembrane domains, a long extracellular loop, and two short intracellular segments (Knaus et al., 1994Go), leaving little to construct an intracellular binding site for puerarin. Because puerarin can activate the BKCa channels only when applied to the cytoplasmic side of cell membrane, we infer that puerarin-binding sites are located on the intracellular side of the {alpha} subunits. The N terminus and S0 of the BK-{alpha} subunit have been supposed to be the possible regions to regulate the gating of BKCa channels via interacting with beta1 subunits (Wallner et al., 1996Go). We examined the effect of puerarin on dslo; interestingly, no action was observed. Aligning the sequences of mslo and dslo, we find that there is main difference in two cytoplasmic motifs, i.e., the S0-S1 linker and S8-S9 linker. The sites for puerarin binding to BKCa channels may be located in one of these domains. More experiments are needed to determine the precise locations. As we know, both dslo and mslo channels contain the same calcium binding sites in RCK1 (regulator of conductance for K+) domain and calcium bowl regions but have very different Ca2+ sensitivity (Xia et al., 2002Go). Furthermore, considering that the S0-S1 and S8-S9 linkers are the major differences in the sequences between dslo and mslo channels, we speculate that they could be the candidates of locations affecting Ca2+ sensitivity of BKCa channels.

The Function of the Glycosyl Residue of Puerarin. Puerarin is an isoflavone glycoside with a beta-D-glucopyranoside at 8-position and two hydroxyl groups at 4', 7-positions. The isoflavone nucleus is a rigid and hydrophobic structure, whereas the glycosyl residue and hydroxy group are hydrophilic. Daidzein, an analog of puerarin, has no glycosyl residue and activates BKCa channels with weaker potency than puerarin. These results indicate that the beta-D-glucopyranoside at 8-position plays an important role in puerarin activating BKCa channels. Thus, engineering in new BKCa channel openers should focus on the modification of the number or location of glycosyl group in the isoflavone nucleus.

Vasodilation and the Activation of BKCa Channels Induced by Puerarin. Puerarin caused concentration-dependent relaxations in isolated rat thoracic aortic rings contracted with NA. IbTX, a specific BKCa channel blocker, markedly inhibited puerarin-induced relaxations. It is likely, therefore, that the mechanism of this response to puerarin involves opening of BKCa channels. In the absence of endothelium, puerarin produced less relaxation than that in the presence of endothelium, indicating that endothelium was also involved in puerarin-mediated vasodilation. However, the inhibition of relaxation by IbTX was not decreased in the absence of endothelium, implying that the contribution of BKCa channels to puerarin-mediated vasodilation is independent to the endothelium. It is worth noting that the EC50 of puerarin required to relax aortic rings (1.1 µM) was ~1000-fold higher than that required to directly activate BKCa channels. This difference is attributed to the fact that puerarin hardly penetrates the cell membrane as mentioned above. However, puerarin could be taken into the cytoplasm through endocytosis. The average diameter of a vesicle is about 140 nm (Zhang et al., 1995Go), so each vesicle could carry drugs in 3 x 10–6 of the extracellular concentration into a 10 µm cell in diameter. There are about 200 vesicles taking part in one secretion event (Gillis et al., 1996Go), and from this we can calculate that the concentration of puerarin in the cytoplasm of vascular smooth muscle cells would be in 6 x 10–4 of the extracellular concentration, which would be the concentration activating the BKCa channels. The plasma concentration of puerarin is in the range of 1 to 1000 µM in humans and animals (Jin et al., 1991Go; Deng et al., 2004Go; Wu et al., 2004Go), so the concentration used in this study is of therapeutic relevance.

In summary, we have provided direct evidences for the activation of cloned BKCa channels by puerarin, and shown that BKCa channel activation contributes to puerarin-induced vasodilation, which is likely to be a mechanism by which puerarin exerts its action on rat thoracic aortas, in addition to its activation of endothelial nitric-oxide synthase and cAMP pathway, as demonstrated by other investigators (Ma et al., 2003Go; Yeung et al., 2006Go). The present findings are of interest for understanding the contribution of BKCa openers to lowering blood pressure and improving other cardiovascular symptoms.


    Acknowledgements
 
We thank Dr. Geng Hui, Dr. Tao Yunhai, and Dr. Gao Shangbang for helpful discussions. We thank Prof. Chen Jianguo and Dr. Wang Fang for guidance in vasoreactivity experiments. We thank Prof. John Cram and Prof. He Guangyuan for critical comments on the manuscript.


    Footnotes
 
This work was supported by Grants 30500109 and 30470449 from the Natural Science Foundation of China and the Excellent Doctoral Thesis Research Foundation from Huazhong University of Science and Technology (to S.X.H.).

Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

doi:10.1124/jpet.107.125567.

ABBREVIATIONS: BKCa channel, the large-conductance calcium-activated potassium channel; BK-{alpha}, the {alpha} subunit of BKCa channels; BK-{alpha}+beta1, the {alpha} and beta1 subunit of BKCa channels; slo, the {alpha} subunit of BKCa channels; mslo, mouse slo; dslo, drosophila slo; hbeta1, human beta1; NA, noradrenaline bitartrate; IbTX, iberiotoxin; HEK, human embryonic kidney; NPO, the open probability for a multichannel patch; BMS-204352, (3S)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one.

Formula S The online version of this article (available at http://jpet.aspetjournals.org) contains supplemental material. Back

Address correspondence to: Xiang-Liang Yang, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, PR China. E-mail: yangxl{at}mail.hust.edu.cn


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

Amberg GC, Bonev AD, Rossow CF, Nelson MT, and Santana LF (2003) Modulation of the molecular composition of large conductance, Ca2+ activated K+ channels in vascular smooth muscle during hypertension. J Clin Invest 112: 717–724.[CrossRef][Medline]

Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, and Aldrich RW (2000) Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 407: 870–876.[CrossRef][Medline]

Chang T, Wu L, and Wang R (2006) Altered expression of BK channel beta1 subunit in vascular tissues from spontaneously hypertensive rats. Am J Hypertens 19: 678–685.[CrossRef][Medline]

Chen X (2004) [The clinical observation of puerarin injection on unstable angina pectoris.] Zhong Yao Cai 27: 77–78. Chinese.[Medline]

Deng XG, Hu SX, Zhang QJ, Yang JN, Lin SC, and Chen K (2004) [Pharmacokinetic study of puerarin in retinal tissue of rabbits by intraperitoneal injection.] Zhong Cao Yao 35: 1382–1384. Chinese.

Dong K, Tao QM, Xia Q, Shan QX, and Pan GB (2004) [Endothelium-independent vasorelaxant effect of puerarin on rat thoracic aorta.] Zhongguo Zhong Yao Za Zhi 29: 981–984. Chinese.[Medline]

Gao FY (2003) [Pharmacological progress of puerarin.] Zhong Cao Yao 34: 7–8. Chinese.

Giangiacomo KM, Kamassah A, Harris G, and McManus OB (1998) Mechanism of maxi-K channel activation by dehydrosoyasaponin-I. J Gen Physiol 112: 485–501.[Abstract/Free Full Text]

Gillis KD, Mößner R, and Neher E (1996) Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron 16: 1209–1220.[CrossRef][Medline]

Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, et al. (2001) Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 7: 471–477.[CrossRef][Medline]

Jin XL, Cheng GF, and Zhu XY (1991) [Pharmacokinetics of puerarin in healthy volunteers.] Zhongguo Linchuang Yaolixue Zazhi 7: 115–118. Chinese.

Knaus HG, Eberhart A, Kaczorowski GJ, and Garcia ML (1994) Covalent attachment of charybdotoxin to the beta-subunit of the high-conductance Ca2+-activated K+ channel. J Biol Chem 269: 23336–23341.[Abstract/Free Full Text]

Ma JJ, Ma H, Wang YM, Li HM, and Pei JM (2003) [Vasodilation effect of puerarin on abdominal aortic artery in the rat and the underlying mechanism.] Disi Junyi Daxue Xuebao 24: 2231–2234. Chinese.

McCartney CE, McClafferty H, Huibant JM, Rowan EG, Shipston MJ, and Rowe IC (2005) A cysteine-rich motif confers hypoxia sensitivity to mammalian large conductance voltage- and Ca-activated K(BK) channel {alpha}-subunits. Proc Natl Acad Sci USA 102: 17870–17876.[Abstract/Free Full Text]

Miao WN, Shen YJ, and Zeng XR (1998) [Effect of puerarin on K+ channel of isolated ventricular myocytes in guinea pig.] Zhongguo Yingyong Shenglixue Za Zhi 18: 155–158. Chinese.

Pérez GJ (2005) Dual effect of tamoxifen on arterial KCa channels does not depend on the presence of the beta1 subunit. J Biol Chem 280: 21739–21747.[Abstract/Free Full Text]

Plüger S, Faulhaber J, Furstenau M, Lohn M, Waldschutz R, Gollasch M, Haller H, Luft FC, Ehmke H, and Pongs O (2000) Mice with disrupted BK channel beta1 subunit gene feature abnormal Ca2+ spark/STOC coupling and elevated blood pressure. Circ Res 87: E53–E60.[Medline]

Qian Y, Li Z, Huang L, Han X, Sun J, Zhou H, and Liu Z (1999) Blocking effect of puerarin on calcium channel in isolated guinea pig ventricular myocytes. Chin Med J (Engl) 112: 787–789.[Medline]

Sakamoto K, Nonomura T, Ohya S, Muraki K, Ohwada T, and Imaizumi Y (2006) Molecular mechanisms for large conductance Ca2+-activated K+ channel activation by a novel opener,12,14-dichlorodehydroabietic acid. J Pharmacol Exp Ther 316: 144–153.[Abstract/Free Full Text]

Sausbier M, Arntz C, Bucurenciu I, Zhao H, Zhou XB, Sausbier U, Feil S, Kamm S, Essin K, Sailer CA, et al. (2005) Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice. Circulation 112: 60–68.[Abstract/Free Full Text]

Song XP, Chen PP, and Chai XS (1988) [Effects of puerarin on blood pressure and plasma rennin activity in spontaneously hypertensive rats.] Acta Pharmacol Sin 9: 55–58.

Sun YX, and Li JQ (2002) [The vasodilation effect of puerarin and underlying mechanism.] Zhong Cao Yao 33: 733–734. Chinese.

Wallner M, Meera P, and Toro L (1996) Determinant for beta-subunit regulation in high-conductance voltage-activated and Ca2+-sensitive K+ channels: An additional transmembrane region at the N terminus. Proc Natl Acad Sci U S A 93: 14922–14927.[Abstract/Free Full Text]

Wang Q, Wu T, Chen X, Ni J, Duan X, Zheng J, Qiao J, Zhou L, and Wei J (2006) Puerarin injection for unstable angina pectoris. Cochrane Database Syst Rev 3: CD004196.[Medline]

Wu XP, Feng JG, Chen HM, Cheng F, Zhang L, Wei Z, and Chen W (2006) [Protective effects of puerarin against myocardial injury in patients with hypertension during perioperational period.] Zhongguo Zhong Xi Yi Jie He Za Zhi 26: 255–257. Chinese.[Medline]

Wu YH, Su Z, Lai XP, Yao H, and Lin J (2004) [Studies on pharmacokinetics and bioavailability of puerarin in Yufeng Ningxin tablet in mice.] Zhongyao Xinyao yu Linchuang Yaoli 15: 259–261. Chinese.

Xia XM, Ding JP, and Lingle CJ (1999) Molecular basis for the inactivation of Ca2+- and voltage-dependent BK channels in adrenal chromaffin cells and rat insulinoma tumor cells. J Neurosci 19: 5255–5264.[Abstract/Free Full Text]

Xia XM, Zeng XH, and Lingle CJ (2002) Multiple regulatory sites in large-conductance calcium-activated potassium channels. Nature 418: 880–884.[CrossRef][Medline]

Xiao LZ, Gao LJ, and Ma SC (2005) [Comparative study on effects of puerarin and granulocyte colony-stimulating factor in treating acute myocardial infarction.] Zhongguo Zhong Xi Yi Jie He Za Zhi 25: 210–213. Chinese.[Medline]

Yao J, Chen X, Li H, Zhou Y, Yao L, Wu G, Chen X, Zhang N, Zhou Z, Xu T, et al. (2005) BmP09, a "long chain" scorpion peptide blocker of BK channels. J Biol Chem 280: 14819–14828.[Abstract/Free Full Text]

Yeung DK, Leung SW, Xu YC, Vanhoutte PM, and Man RY (2006) Puerarin, an isoflavonoid derived from radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. Eur J Pharmacol 552: 105–111.[CrossRef][Medline]

Zakharov SI, Morrow JP, Liu G, Yang L, and Marx SO (2005) Activation of the BK (SLO1) potassium channel by mallotoxin. J Biol Chem 280: 30882–30887.[Abstract/Free Full Text]

Zhang GQ, Hao XM, Dai DZ, Fu Y, Zhou PA, and Wu CH (2003) Puerarin blocks Na+ current in rat ventricular myocytes. Acta Pharmacol Sin 24: 1212–1216.[Medline]

Zhang GQ, Hao XM, Ma YP, Zhou PA, Wu CH, and Dai DZ (2001) Characteristics of the delayed rectifier K+ current in guinea pig hypertrophied ventricular myocytes induced by thyroxine. Chin Pharmacol Bull l17: 174–177.

Zhang S, Chen S, Shen Y, Yang D, Liu X, Sunchi AC, and Xu H (2006) Puerarin induces angiogenesis in myocardium of rat with myocardial infarction. Biol Pharm Bull 29: 945–950.[CrossRef][Medline]

Zhang X, Aman K, and Hokfelt T (1995) Secretory pathways of neuropeptides in rat lumbar dorsal root ganglion neurons and effects of peripheral axotomy. J Comp Neurol 352: 481–500.[CrossRef][Medline]



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.107.125567v1
323/1/391    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, X.-H.
Right arrow Articles by Xu, H.-B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, X.-H.
Right arrow Articles by Xu, H.-B.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition